CVE-2022-45611

CRITICAL

9.8

Description

An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.

CVE Details

CVSS v3.1 Score9.8

SeverityCRITICAL

CVSS VectorCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Attack VectorNETWORK

ComplexityLOW

Privileges RequiredNONE

User InteractionNONE

Published8/22/2023

Last Modified11/21/2024

Sourcenvd

Honeypot Sightings0

Affected Products

fresenius-kabi:pharmahelpfresenius-kabi:pharmahelp_firmware

Weaknesses (CWE)

CWE-522

References

https://www.fresenius-kabi.com/de-at/produkte/pharmahelp-compounder(cve@mitre.org)

https://www.fresenius.com/sites/default/files/2023-11/Fresenius%20-%20CVE-2022-45611.pdf(cve@mitre.org)

https://www.fresenius.com/sites/default/files/2023-12/Fresenius%20-%20CVE-2022-45611.pdf(cve@mitre.org)

https://www.fresenius-kabi.com/de-at/produkte/pharmahelp-compounder(af854a3a-2127-422b-91ae-364da2661108)

https://www.fresenius.com/sites/default/files/2023-11/Fresenius%20-%20CVE-2022-45611.pdf(af854a3a-2127-422b-91ae-364da2661108)

https://www.fresenius.com/sites/default/files/2023-12/Fresenius%20-%20CVE-2022-45611.pdf(af854a3a-2127-422b-91ae-364da2661108)

IOC Correlations

No correlations recorded

This product uses data from the NVD API but is not endorsed or certified by the NVD.